A12G (p.Ala12Gly) variant of BEST1 (Bestrophin-1)

A12G (p.Ala12Gly) in BEST1 (Bestrophin-1) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Vitelliform macular dystrophy 2; Retinal dystrophy. The available variant effect predictions contribute to a CATVariant prioritization score of 0.73 / 1. The record also includes published literature and structural context.

A12G (p.Ala12Gly) variant details